Each method has its place
Functioning as a triple agonist of the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1), and glucagon receptors, retatrutide is poised to redefine weight management
Professor Anton Pottegrd, from the University of Southern Denmark, and coauthors analyzed databases from six countries, comparing patients with type 2 diabetes between 2007 and 2023 for the risk of thyroid cancer among GLP1-RA users compared with dipeptidyl peptidase-4 inhibitors (DPP-4is)
162 Moreover, restricted intake of dietary protein or methionine/cystine has been shown to modify the infiltration and tumoricidal capacity of TAMs, leading to a significant increase in tumor-infiltrating CD8 + T cells and a decrease in the number of infiltrating MDSCs
The drugs mimic GLP-1, a hormone the body produces after eating, which can decrease appetite and help the body manage insulin production
Effective for significant weight loss